SIRT5 and breast cancer: Moreover, SIRT5 has a dichotomous function in lung cancer [46,66,82,118], hepatocellular carcinoma (HCC) [63,119,120,121], and breast cancer [69,70], demonstrating that its activity ultimately depends on the particular environment and not only on the kind of tissue or cancer type.